he present opioid use epidemic has garnered significant attention. Over the last 16 years, more than 183 000 Americans have died from overdose related to prescription opioid use. 1,2 The epidemic has set off ripples among policy makers. The US Food and Drug Administration has launched the Opioid Policy Steering Committee to explore and develop strategies to confront the crisis. The committee looks to answer, among other things, whether physicians are informed adequately regarding prescribing recommendations and whether clinicians are prescribing the appropriate number of doses for a given medical indication. Most people who eventually become addicted to opioids are first exposed through prescription medications. 3 Efforts to combat the current situation are now being focused on the pharmaceutical industry supplying the medications and physicians who are doing the prescribing. We set forth to understand better the opioid prescribing habits of ophthalmologists and seek to better elucidate our role in the prescription opioid abuse epidemic. Methods The Centers for Medicare and Medicaid Services' Medicare Provider Utilization and Payment Data were accessed to gather the data for analysis, starting in June 2017. Specifically, we analyzed Medicare Part D Prescriber data 4 for 2013 to 2015 (the only IMPORTANCE Drug overdoses have become the number 1 cause of mortality in American adults 50 years and younger. Prescription opioid abuse is a growing concern that has garnered widespread attention among policymakers and the general public. OBJECTIVE To determine the opioid prescribing patterns among ophthalmologists and elucidate their role in the prescription opioid abuse epidemic.